本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Principia Biopharma Inc.

100.05
0.0000
成交量:- -
成交額:- -
市值:33.28億
市盈率:-44.01
高:100.05
開:100.05
低:100.05
收:100.05
52周最高:101.89
52周最低:25.35
股本:3,325.99萬
流通股本:2,304.04萬
量比:- -
換手率:- -
股息:- -
股息率:- -
每股收益(TTM):-2.2732
每股收益(LYR):-2.0867
淨資產收益率:-26.40%
總資產收益率:-16.03%
市淨率:9.47
市盈率(LYR):-47.95

資料載入中...

2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/10/01

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/09/28

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2020/09/28

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2020/09/28

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2020/09/28

交易所摘牌聲明

25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2020/09/28

重要事件披露

8-K - Current report
2020/09/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/08/25

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2020/08/19

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/08/17

重要事件披露

8-K - Current report
2020/08/06

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/08/06

重要事件披露

8-K - Current report
2020/06/26

重要事件披露

8-K - Current report
2020/06/12

重要事件披露

8-K - Current report
2020/06/09

重要事件披露

8-K - Current report
2020/05/06

季度報告

Quarterly report [Sections 13 or 15(d)]
2020/05/06

重要事件披露

Current report, items 2.02 and 9.01
2020/04/24

重要事件披露

Current report, item 8.01
2020/03/10

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans